Sunday 20 October, 2019
Edition: English (US)
MMJ Observer

This year has seen Kalytera Therapeutics (OTCMKTS:KALTF) engaged in numerous deals aimed at expanding the company’s scope. The company has set clear objectives concerning what it expects to achieve this year. One of these objectives is to...

By Steven Russell on Jul 3rd, 2019

Kalytera Therapeutics, Inc. (OTCMKTS:KALTF) has announced that it has elected to issue common shares of the company to the Salzman Group in payment of the invoices issued under a payments agreements with Salzman Group that was announced on Mid-June...

By Elizabeth Jackson on Feb 7th, 2019

Kalytera Therapeutics Inc (OTCMKTS:KALTF) has announced that it made a significant breakthrough with a cannabinoid-based developmental treatment for acute and chronic pain. The announcement revealed that the cannabinoid compound treatment features...

By Melissa Kay on Oct 29th, 2018

Kalytera Therapeutics Inc (OTCMKTS:KALTF) has disclosed that it will on Tuesday hold a meeting with the Center for Drug Evaluation and Research. This happens to be one of the departments under U.S. Food and Drug Administration. This meeting...

By Rebecca Harrison on Jul 24th, 2018

Don’t Just Beat the Market, Crush It!

Let’s put the power in your hands. I do the work, find, and reveal up to 10 simple trades each week that can make you a killing. Learn my system. Trade my system. Keep all the profits.
**Limited only for the next 47 visitors
Click Me